UNC1215 is primarily used in biochemical research as a potent and selective chemical probe targeting the L3MBTL3 protein, a member of the malignant brain tumor (MBT) family of chromatin readers. It is widely employed in studies focused on understanding the role of L3MBTL3 in epigenetic regulation, particularly in processes such as gene expression, chromatin remodeling, and cellular differentiation. Researchers utilize UNC1215 to investigate how L3MBTL3 interacts with methylated histones and other proteins, shedding light on its involvement in cancer biology and other diseases linked to epigenetic dysregulation. Additionally, UNC1215 serves as a valuable tool in drug discovery efforts, helping to identify and validate potential therapeutic targets within the epigenetic machinery. Its high specificity and efficacy make it a key reagent in advancing the understanding of chromatin-associated proteins and their biological functions.